pembrolizumab,efineptakin alfa
merck,neoimmunetech
['pembro', 'neoimmune']
new evidence of #neoimmunetechs #nti7 clinical efficacy in combination with #pembrolizumab in #relapsed #refractory #gastrointestinaltumors #sitc22 